A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
Novo Nordisk will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst ...
Telehealth firms Teladoc Health and LifeMD said on Thursday they have signed an agreement with Eli Lilly's direct-to-consumer ...
A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...
9h
Health on MSNZepbound Is Now Available in Additional Doses at Lower CostsEli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.
Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” fourth quarter 2024 investor ...
While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...
Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its ...
One of the few drug developers based in Worcester is leaving Wormtown for Waltham. Also, Novo Nordisk and Eli Lilly have ...
A U.S. federal judge has denied an injunction that would have allowed compounding pharmacies to keep making copies of Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results